Xenon Pharmaceuticals Inc. (XENE) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Xenon Pharmaceuticals Inc. (XENE) closed at USD 33.90 on 2026-10-14, a change of -20.3 % over the past year, with a market capitalization of USD 3.32B.

Xenon Pharmaceuticals Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Xenon Pharmaceuticals Inc. key figures

Previous close

USD 33.90 (2026-10-14)

1-year change

-20.3 %

Market cap

USD 3.32B

Enterprise value

USD 2.4B

P/E ratio (trailing)

-7.26

P/E ratio (forward)

-7.27

EPS (trailing)

-4.73

EPS (forward)

-4.72

PEG ratio

n/a

Price to book

2.67

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.69

Employees

358

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders. Its product candidates include Azetukalner, a novel, potent Kv7 potassium channel opener which is in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. In addition, the company's Phase 1 Single Ascending Dose/Multiple Ascending Dose products include XEN1701 targeting the sodium channel and XEN1120 targeting the Kv7 potassium channel for the treatment of pain. The company has a license and collaboration agreement with Neurocrine Biosciences, Inc. for the development of NBI-921355, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Xenon Pharmaceuticals Inc. and compare it with other stocks.